Sanofi is expanding its partnership with Regeneron Pharmaceuticals through an agreement valued at up to $8 billion, strengthening their collaboration in the pharmaceutical sector.

The deal represents a significant development for Sanofi and comes as the company continues to work under its new chief executive.

The expanded partnership is expected to deepen cooperation between the two companies and support their ongoing efforts in developing and advancing pharmaceutical products.